The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI) - Scorecard - MDSpire

The application of EPSiT in pilonidal sinus disease: an international Delphi consensus study endorsed by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI)

  • By

  • H. K. Sekhon Inderjit Singh

  • P. Meinero

  • F. C. Campanile

  • A. Quddus

  • R. Rajaganeshan

  • J. Warusavitarne

  • V. Dotlacil

  • A. Bhargava

  • P. Giordano

  • A. Pini Prato

  • V. Shatkar

  • P. Jalali

  • V. C. Halahakoon

  • G. Gallo

  • M. Milone

  • S. Mantoo

  • C. A. Leo

  • C. Esposito

  • M. Farghaly

  • T. Arulampalam

  • N. Pawa

  • July 30, 2025

  • 0 min

Share

Clinical Scorecard: Utilization of EPSiT for Pilonidal Sinus Disease: An International Delphi Consensus Study Supported by the Association of Laparoscopic Surgeons of Great Britain and Ireland (ALSGBI)

At a Glance

CategoryDetail
ConditionChronic pilonidal sinus disease (PD)
Key MechanismsMinimally invasive endoscopic treatment involving diagnostic and therapeutic phases using fistuloscope to remove hairs, cauterise fistula tracts, and remove epithelial/granulation tissue under direct vision
Target PopulationAdults and children with primary or recurrent pilonidal sinus disease
Care SettingSurgical setting with prone patient positioning, single-dose antibiotic prophylaxis, and post-operative outpatient wound care

Key Highlights

  • EPSiT and VAAPS are minimally invasive alternatives to traditional surgery with reduced complications, pain, hospital stay, and faster recovery.
  • Despite benefits, EPSiT uptake remains low in the UK due to evolving evidence, lack of guidelines, training gaps, and technique modifications.
  • Delphi consensus study aims to standardise EPSiT technique and improve adoption, endorsed by ALSGBI with expert international surgeon participation.

Guideline-Based Recommendations

Diagnosis

  • Perform diagnostic phase using fistuloscope to identify sinus cavity and fistula tracts under direct vision.

Management

  • Administer single-dose antibiotic prophylaxis pre-operatively.
  • Make a 5-mm incision around the discharging sinus for fistuloscope introduction.
  • Remove all hairs inside the sinus with forceps.
  • Cauterise fistula cavity and tracts with electrode.
  • Remove epithelial and granulation tissue with endobrush or Volkmann spoon.
  • Infuse glycine/mannitol 1% solution during EPSiT procedure.
  • Post-operative wound care with light dressing, no packing, and once-daily saline wound washing for at least 2 weeks.

Monitoring & Follow-up

  • Monitor for wound infection, wound dehiscence, seroma, and haematoma, noting reduced incidence compared to conventional surgery.
  • Assess for disease recurrence, acknowledging no significant difference in recurrence rates compared to traditional surgery.

Risks

  • Potential for disease recurrence similar to conventional surgery.
  • Possible complications include wound infection, wound breakdown, seroma, and haematoma, though rates are reduced.

Patient & Prescribing Data

Patients with limited or recurrent pilonidal sinus disease undergoing EPSiT.

EPSiT offers reduced post-operative pain, shorter hospital stay, and faster return to daily activities compared to conventional surgery, but recurrence risk remains similar.

Clinical Best Practices

  • Standardise EPSiT technique to improve uptake and outcomes.
  • Use prone positioning and single-dose antibiotic prophylaxis during procedure.
  • Employ direct vision endoscopic approach with appropriate irrigation solution (glycine/mannitol 1%).
  • Avoid wound packing post-operatively; use light dressing and daily saline irrigation.
  • Incorporate EPSiT training into surgical education to address current uptake barriers.
  • Consider EPSiT as treatment of choice for limited disease and apply same approach for recurrent disease.

References

Original Source(s)

Related Content